Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484470 · ClinicalTrials.gov registry record · Phase 2
Umbilical Cord Transplantation for the Elderly Population
A Phase 2 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT01484470 is a Phase 2 study that has completed, run by Loyola University. The registered enrollment target is 18 participants.
The verdict
NCT01484470, a Phase 2 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
While cord blood transplants have been performed safely in elderly patients, many still relapse. The investigators propose to intensify the preparative regimen for this patient group in an attempt to decrease relapses, and combine this with an ex vivo expanded Umbilical Cord Blood (UCB) unit.
Interventions
- BIOLOGICAL StemEx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-01 |
| Est. Completion | 2018-11-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484470
The ClinicalTrials.gov registry entry for NCT01484470 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which StemEx is the first listed.
NCT01484470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01484470 about?
NCT01484470 is a clinical study titled "Umbilical Cord Transplantation for the Elderly Population". While cord blood transplants have been performed safely in elderly patients, many still relapse. The investigators propose to intensify the preparative regimen for this patient group in an attempt to decrease relapses, and combine this with an ex vivo expanded Umbilical Cord Blood (UCB) unit.
What is the current status of trial NCT01484470?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2010-01. Estimated completion is 2018-11-21.
What interventions are being tested in trial NCT01484470?
The interventions under investigation include: StemEx (BIOLOGICAL).
Who is sponsoring clinical trial NCT01484470?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.